Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2021 Standout
Small-molecule fluorescence-based probes for interrogating major organ diseases
2021 Standout
Works of A. Kumar being referenced
Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| A. Kumar | 162 | 6 | 61 | 143 | 81 | 14 | 392 | |
| Ian D. Wells | 50 | 13 | 45 | 138 | 100 | 21 | 455 | |
| R Harf | 37 | 3 | 89 | 71 | 97 | 22 | 372 | |
| Gianluca Galazzo | 71 | 48 | 85 | 22 | 13 | 445 | ||
| Christina Kumpitsch | 58 | 2 | 79 | 76 | 87 | 13 | 405 | |
| Tapio Seiskari | 57 | 18 | 61 | 65 | 15 | 16 | 352 | |
| Mark P. Rondeau | 53 | 4 | 40 | 39 | 101 | 15 | 388 | |
| Susan Lapthorne | 57 | 1 | 45 | 105 | 36 | 18 | 406 | |
| Lars Nyman | 57 | 6 | 56 | 27 | 49 | 14 | 413 | |
| Halil Kocamaz | 48 | 17 | 114 | 22 | 37 | 29 | 385 | |
| Alicia Pérez | 102 | 2 | 96 | 36 | 64 | 12 | 378 |
All Works
Login with ORCID to disown or claim papers
Loading papers...